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Abstract: 
The functional sites were predicted for Nudix enzymes from pathogenic microorganisms such as Streprococcus pneumonia (2B06) and Enterococcus 
faecalis (2AZW). Their structures are already determined, however, no data is reported about their functional sites, substrates and inhibitors. Therefore, 
we report prediction of functional sites in these Nudix enzymes via Geometric Invariant (GI) technique (Construct different geometries of peptides which 
remain unchanged). The GI method enumerated 2B06: RA57, EA58, EA61, EA62 and 2AZW: RA62, EA63, EA66, EA67 as putative functional sites in 
these Nudix enzymes. In addition, the substrate was predicted via Molecular docking (Docking of substrates against whole structure of Nudix enzymes). 
The substrate ADP-Ribose was docked with the Nudix enzymes, 2B06 (Docking energy -15.68 Kcal/mol) and 2AZW (Docking energy -10.86 Kcal/mol) 
with the higher affinity and the lower docking energy as compared to other substrates. The residues EA62 in 2B06 and RA62 in 2AZW make hydrogen 
bonds with the ADP-ribose. Furthermore, we screened 51 inhibitor compounds against structures of 2B06 and 2AZW. The inhibitor compounds AMPCPR 
and CID14258187 were docked well as compared to other compounds. The compound CID14258187 was also in agreement with Lipinski rule of 5 for 
drug likeness properties. Therefore, our findings of functional sites, substrates and inhibitors for these Nudix enzymes may help in structure based drug 
designing against Streprococcus pneumonia and Enterococcus faecalis. 
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Background : 
Nudix (nucleoside phosphatase linked to x) enzymes are found in several 
diverse types of organisms such as viruses [1], bacteria [2] archaea [3], and 
eukaryotes  [4].  They  catalyze  the  hydrolysis  of  nucleoside  and 
deoxynucleoside  triophosphate  attached  functional  groups  or  chemical 
species, referred to as x [5, 6]. Nudix enzymes remove mutation inducing 
nucleotide  such  as  8-oxy-dGTP  from  the  cell,  which  tends  to  interfere 
DNA replication process causing several thousand fold increase in AT-CG 
transversion  mutation  rate  [7].  In  addition,  these  enzymes  catalyze  the 
catabolism of cellular toxic compounds so that their cytotoxic effects on 
the bacterial cell can be removed [8-10]. Thus, the Nudix enzymes perform 
a key role in protecting the cells from oxidative damage by radiation and 
from  toxic  effects  of  accumulated  metabolites  [11-12].  Moreover,  these 
enzymes are implicated in cell signaling [11-12], maintaining the level of 
signaling compounds inside the cell [5]. Due to their protective roles in cell 
survival,  the  Nudix  enzymes  can  be  potential  targets  for  antimicrobial 
drugs  in  pathogenic  organisms  such  as  African  Swine  Fever  Virus  [1], 
Streprococcus pneumonia and Enterococcus faecalis. These enzymes are 
characterized by a highly conserved Nudix box sequence motif G-X(5)-E-
X(7)-R-E-U-X-E-E-X-G-U,  where  the  conserved  residues  are  separated 
by X (any residues) and U, a bulky hydrophobic residue.  The Nudix box 
acts as a catalytic centre [13] and is often found in loop-alpha-helix-loop 
[9].  
 
Due to key role of Nudix enzymes in bacterial cell survival, we targeted 
these  enzymes  from  pathogenic  microorganisms  such  as  Streprococcus 
pneumonia (2B06) and Enterococcus faecalis (2AZW) for the functional 
sites,  substrates  and  inhibitors  prediction.  Their  structures  have  been 
determined and submitted in RCSB protein data bank. However, no data 
has  been  reported  about  their  functional  sites,  substrates  and  inhibitors. 
Although,  several  biochemical techniques have  been used  to predict  the 
functional  sites,  however,  these  techniques  are  time  consuming  and  not 
cost  effective.  Therefore,  we  used  combined  computational  approach  of 
Geometric Invariant (GI) and Molecular docking methods  for  functional 
sites,  substrates  and  inhibitor  prediction  in  Nudix  enzymes  2B06  and 
2AZW. 
   
Methodology: 
Input files : 
Dataset creation: 
We obtained structures of Nudix enzymes, 2B06 and 2AZW, from RCSB 
protein  data  bank.  Then,  these  structures  were  further  subjected  to 
Geometric  Invariant  calculator  and  enumerated  putative  substructures 
(amino  acid  patterns  of  4-6  residues  obtained  from  whole  protein 
structures) based on their geometric properties such as area, volume, and 
perimeter. Please refer the following paper for detail of GI method [14, 15] 
(Table 1 See Supplementary material).  
 
Library of functional sites:  
The library of functional sites was constructed using 10751 non-redundant 
proteins  from  the  PDB  as  available  in  level  2  of  NCBI’s  molecular 
modeling  database  (MMDB).  It  contains  959  clusters  of  amino  acid 
patterns of size 4-6 residues covering 136 GO terms. Each substructure is 
described with a number of descriptors that are invariant upon rotation and Bioinformation  Volume 5  open access 
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translation  transformations  and  hence  are  called  as  geometric  invariant 
(GIs). For instance, we used 27, 45 and 72 descriptors to represent four, 
five  and  six  sized  substructures.  The  example  descriptors  are  distance 
between  two  vertices,  perimeter, volume, and  surface area of geometric 
objects [15]. 
 
Comparison of functional sites: 
The substructures from 2B06 and 2AZW were compared with the library 
of  functional  sites  reported  earlier  and  having  compatible  amino  acid 
composition. The geometric similarity between a certain substructure and 
the site leads to declaration of that substructure as a putative functional site 
(Table 5 see Supplementary material) [15].  
 
Substrate prediction: 
We used molecular docking method for prediction of substrates and their 
binding sites in 2B06 and 2AZW.  The substrates were selected from pdb 
files and literature of the template proteins present in the matched cluster 
(from GI method). The SMILES strings of substrates were obtained from 
PUBCHEM database (http://pubchem.ncbi.nlm.nih.gov/) and converted in 
to  3D  via  using  CORINA  server  (www.molecular-networks.com/ 
online_demos/corina_demo.html). The substrates were docked against the 
Nudix target 2B06 and 2AZW in two settings: (i) Blind docking and (ii) 
Refined docking. The blind docking considers the whole structure of the 
Nudix enzymes as docking target,  while in refined docking, we specifies 
the functional sites ( predicted by our GI method) as docking target and 
generates the grid map with grid points spacing at 0.375A. The docking 
experiments were performed via using AUTODOCK4.0 [16]. All docking 
parameters were set to be default (Figure 1).  
 
Binding site analysis:  
The  substrates  were  ranked  based  on  the  lowest  docking  energy  of  the 
blind docking by including residues with in 6A
0 radius from the substrate 
(as center).   
 
Inhibitor Prediction: 
The inhibitor compounds for the 2B06 and 2AZW Nudix enzymes were 
obtained from the literature and searched in the PUBCHEM database for 
finding  of  similar  compounds.  The  SMILES  strings  of  all  the  inhibitor 
compounds  were  downloaded  and  converted  in  to  3D  structures  via 
CORINA server. The compounds were further docked against the whole 
structures of 2B06 and 2AZW via PATCHDOCK software [17] and ranked 
based on the Docking score.  Top ranked inhibitor compound was selected 
for  analysis  of  drug  likeness  properties  via  MOLINSPIRATION  server 
(www.molinspiration.com). 
 
Results: 
We  divided our research  work results in three parts:  (1) Functional  site 
prediction in 2B06 and 2AZW, (2) Substrates prediction and (3) Inhibitor 
prediction. Here we described the details of our predictions: 
 
Functional site prediction: 
Nudix  enzymes  from  Streptococcus  pneumoniae  (2B06)  and 
Enterococcus faecalis (2AZW): 
Streptococcus pneumoniae, or pneumococcus, is a gram-positive anaerobic 
bacterium from genus Streptococcus. It causes bacterial meningitis in both 
adults and children.  It also  causes various  pneumococcal infections like 
acute sinusitis, otitis media, sepsis, endocarditis etc. On the other hand, the 
Enterococcus faecalis is a gram positive  facultative anaerobic bacterium 
homing gastrointestinal tracts of human. It causes sever infections such as 
endocarditis as well as infections in gal bladder, prostate and epididymal 
surface in Humans. The Nudix enzymes 2B06 and 2AZW may participate 
in the cell survival of Streptococcus pneumoniae and Enterococcus faecalis 
bacteria’s in adverse environment.  
 
We predicted following functional sites in the 2B06: RA57, EA58, EA61, 
EA62  and  2AZW:  RA62,  EA63,  EA66,  EA67  Nudix  enzymes  via  GI 
method based on a match with cluster DDDK-1 in the library. The cluster 
DDDK-1 contains functional sites of four known Nudix enzymes: (i) MutT 
Nudix from Caenorhabditis elegans (1KTG: E.C.3.6.1.17: RA51, EA52, 
EA55, EA56), (ii) Nudix enzyme from Escherichia coli (1VHZ: E.C.3.6.1: 
RA94,  EA95,  EA98,  EA99)  and  (iii)  Nudix  enzyme  from  Deinococcus 
radiodurans  (1NQZ:  E.C.3.6.1.9:  RA85  EA86  EA89  EA90  and  1SU2: 
RA64  EA65  EA68  EA69)  (Table  1  see  Supplementary  material).  All 
these template proteins are known to perform Hydrolase activities.  Note 
that the 2B06 and 2AZW Nudix enzymes share very low sequence identity 
(less than 25%) with the template proteins.  The predicted sites share the 
following  sequence  pattern:  R-X-E-X  (3)-E-X-E  and  are  present  in  the 
Nudix box motif.  
 
We also analyzed performance of the state of art methods for functional 
sites  predictions  in  2B06  and  2AZW  Nudix  enzymes.  The  sequence 
(BLAST) and structure (DALI)  comparison  of the Nudix targets against 
known proteins in the PDB database strongly establish homology with our 
template proteins of the cluster DDDK-1. PROSITE  server detects Nudix 
hydrolase  signature  motif:  G-x(5)-E-x(4)-[TAGCV]-[LIVMACF]-x-R-
[EL]-[LIVMFGSTA]-x-[EA]-E-x-[GNDTHR] (PS:00893) for 2AZW and 
2B06. However, the PINTS and CSA are unable to predict functional sites 
in these Nudix proteins. PROFUNC and PatchFinder, on the other hand, 
predicted  functional  sites  in  all  the  SG  targets  with  varying  degree  of 
confidences as well as with large number of residues match (Table 2 see 
Supplementary material).  These results are in agreement with residues 
from GI method. 
 
Substrate prediction:  
The docking of the substrates against whole structures of 2B06 and 2AZW 
revealed that the substrate, ADP-Ribose binds the Nudix enzymes in their 
cavities  with  the  lower  docking  energies  of  -15.68  Kcal/mol  (2B06) 
(Figure 2(a)) and -10.86 Kcal/mol (2AZW) (Figure 2(b)) as compared to 
other substrates (Table 3 see Supplementary material).  
 
When we performed refined docking of the ADP-Ribose against putative 
functional sites of 2B06 and 2AZW (predicted by GI method), we  able to 
obtain  lower  docking  energies  of  -16.20  Kcal/mol  (2B06)  and  -10.96 
Kcal/mol (2AZW) than that of blind docking (Table 3 see Supplementary 
material). The docking analysis established the fact that ADP-Ribose is 
the  most  preferred  substrate  for  2B06  and  2AZW  Nudix  enzymes.  We 
observed  that  ADP-Ribose  binds  the  targets  2B06  and  2AZW  in  their 
cavities made up of active site residues predicted by our GI method. The 
amino acid residue EA62 in 2B06 and RA62 in 2AZW makes hydrogen 
bond with the substrate ADP-Ribose (Figure 2(a, b)). 
 
Substrate binding site analysis: 
We  found that the residues, T10, I12, N26, R28, W35, P41, G42, G43, 
H44,  RA57,  EA58,  E62,  KS76,  W78,  YR86,  V88,  E105,  A122,  Y123, 
D124,  L128,  Y142  and  W150  present  in  the  binding  cavity  of  2B06 
surrounding the  substrate  ADP-Ribose  within 6A
0 radius.  On the  other 
hand,  in  case  of  2AZW,  the  following  residues  are  surrounding  ADP-
Ribose substrate with in 6A
0 radius: GA7, RA18, NA40,  FA44, GA48, 
EA49,  EA51, RA62, EA63, EA66, EA67, EA83, YA84, FA85, YA86, 
SA87, HA89, RA90, KA132, RA133, GA134 and RA137. 
 
Functional mechanism: 
We  propose  the  following  functional  mechanism  for  2B06:  One  of  the 
catalytic residues, RA57, may form a hydrogen bond interaction with the 
nearest  water  molecules.  The  two  glutamate  residues,  EA58  and  EA61, 
may be involved in making coordination complex with a magnesium ion. 
Additionally,  these  glutamate  residues  may  make  hydrogen  bonds  with 
surrounding water molecules (W403, W373 and W304), while the water 
molecule,  W318,  may  share  a  hydrogen  bond  with  EA58  and  EA62 
(Figure 3(a)). On the other hand, in 2AZW: We found that the residues 
RA62  and  EA63  are  very  close  to  magnesium  ion  and  may  form  a 
coordination  complex.  These  residues  make  hydrogen  bonds  with  the 
nearest water molecules. For instance, RA62 makes a hydrogen bond with 
W314,  while  EA63  makes  a  hydrogen  bond  with  W275.  Similarly,  the 
glutamate residue, EA66, makes hydrogen bonds with two nearest water 
molecules W204 and W336. The water molecule W259 shares a hydrogen 
bond between residues RA62 and EA63 (Figure 3b). Bioinformation  Volume 5  open access 
www.bioinformation.net  Issue 8  Hypothesis 
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Figure 1:  Overall schematic for prediction of functional sites, substrates and inhibitors for Structural Genomics Nudix enzymes 2B06 and 2AZW from 
Streptococcus pneumoniae and Enterococcus faecalis.  It can be broadly divided into the following steps: (1a) Building library of functional sites from 
known proteins (templates), (1b) Enumeration of substructures from Nudix enzymes 2B06 and 2AZW and mapping them to space spanned by Geometric 
Invariants (GIs), (2) Matching substructures of enzymes with functional sites in the library to obtain putative functional site, (3) Based on matching 
templates, obtain a list of potential substrates for docking analysis, (4) Molecular docking of substrates against Nudix targets: (4a) Blind docking of 
substrates against the target and (4b) Refined docking of substrates against the target, (5) Search putative inhibitors of Nudix enzymes from literature and 
similar compounds from PUBCHEM database, (6) Docking of these inhibitors  (7) Docking analysis that includes (i) Analysis of substrate and inhibitor 
binding in the cavity of Nudix targets, (ii) Extraction of active site residues with in 6A0 radius around the substrate binding site and (iii) hydrogen bond 
analysis at the predicted functional site. 
 
 
Figure 2:   Docking of putative substrates with Structural Genomics Nudix targets (a) The substrate ADP-Ribose (magenta) bound at cavity of 2AZW 
(green) with docking energy of -10.86 Kcal/mol and residues surrounding the bounded substrate at 6 A0 of radius. Here, the residue EA62 makes a 
hydrogen bond with ADP-Ribose. (b)  The substrate ADP-Ribose (magenta) bound at cavity of 2B06 (green) with docking energy of -15.69 Kcal/mol and 
residues surrounding bounded substrates at 6 A0 of radius. The docking has been performed by AUTODOCK 4.0 software.  The docking analyses are 
performed by using Discovery Studio (http://accelrys.com/products/discovery-studio/). Bioinformation  Volume 5  open access 
www.bioinformation.net  Issue 8  Hypothesis 
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Figure 3: Superimposition of predicted functional sites with the matching templates: (a) The putative functional site of 2B06 (green) is superimposed 
with the residues of known Nudix protein 1SU2 (red) (RMSD 0.08 A0). The EA58 and EA61 make hydrogen bonds (blue) with surrounding  water 
molecules (W403, W373 and W304). The water molecule W318 shares a hydrogen bond between glutamate residues at position 58 and 62. (b) The 
putative functional site of 2AZW (green) is superimposed with the residues of known Nudix protein 1NQZ (red) (RMSD 0.16A0). The RA62 and EZ63 
make hydrogen bond with W314 and W275 respectively. The glutamate residue EA66 is involved in making  hydrogen bonds with two nearest water 
molecules W204 and W336. The water molecule W259 is sharing the hydrogen bonding between residues RA62 and EA63. The superimposition of 
patterns is performed by Discovery Studio (http://accelrys.com/products/discovery-studio/). 
 
 
Figure  4:  Docking  of  predicted  inhibitor  compound  within  the  Cavities  of  Nudix  enzymes.  The  compound  CID14258187  (2R,  3R,  4S,  5R)-2-(6-
aminopurin-9-yl)-5-(dichlorophosphoryloxymethyl) oxolane-3, 4-diol) was selected for analysis as it is in agreement of drug likeness properties. (a) The 
compound CID14258187 (magenta) bound at the  cavity  of 2AZW (green)  with  docking  score  of 4268. Here, the residues R62, E63, E66 and E67 
surround the compound CID14258187 at the pocket (b)The compound CID14258187 (magenta) bound at the cavity of 2B06(green) with docking score 
4888.  The  residues  R57,  E62  and  E58  surround  the  compound  CID14258187.  These  analyses  are  performed  by  using  Discovery  Studio  software 
(http://accelrys.com/products/discovery-studio/). Bioinformation  Volume 5  open access 
www.bioinformation.net  Issue 8  Hypothesis 
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Figure 5: It shows the distribution of the Nudix inhibitors based on their docking score against the whole structure of the 2B06 and 2AZW Nudix 
enzymes. The inhibitors AMPCPR and CID14258187 show more affinity for (a) the 2B06 with score of 5292 and 4888 and (b) for 2AZW with higher 
docking score of 4902 and 4268. The docking is performed by Patchdock software. 
 
Inhibitor prediction: 
Docking  of  51  inhibitor  compounds  revealed  that  the  compounds 
AMPCPR and CID14258187 show more affinity for the 2B06 and 2AZW 
as compared to other inhibitor compounds. The compound AMPCPR  is 
produced Patchdock score of 5292 and CID14258187 of 4888 in case of 
2B06, which is higher than other compounds (Figure 5(a)) (Table 6 see 
Supplementary  material)  On  the  other  hand  for  2AZW,  AMPCPR 
produced  score  of  4902  and  CID14258187  of  4268  (Figure  5(b)).  The 
compounds  AMPCPR  and  CID14258187  bind  within  the  binding  site 
pockets  of  these  Nudix  enzymes  and  surround  by  RA57,  EA62  ,EA58 
(2B06)  and  RA62,  EA63,  EA66,  EA67  (2AZW)  binding  sites  residues 
(Figure 4).  Furthermore,  drug likeness  properties analyses revealed that 
the compound CID14258187 shows no violation for the Lipinski rule of 5 
(rules  for  selecting  a  compound  as  a  potential  drug)  (Table  4  see 
Supplementary material). On the other hand, the compound AMPCPR is 
not  in  agreement  of  rule  of  5  (Table  4  see  Supplementary  material). 
Therefore, we predict CID14258187 (2R, 3R, 4S, 5R)-2-(6-aminopurin-9-
yl)-5-(dichlorophosphoryloxymethyl)  oxolane-3,  4-diol)  as  potential 
inhibitor of the Nudix enzymes 2B06 and 2AZW.  
 
Discussion:  
In this work, we predict functional sites, substrates and inhibitors for 2B06 
and 2AZW Nudix enzymes from disease causing micro-organisms such as 
Streptococcus pneumoniae and Enterococcus faecalis. These enzymes may 
act as potential drug targets in these micro-organisms because of their key 
roles  in  cell  survival.  Their  structures  are  already  reported,  however 
functional sites and substrates are still unknown. Therefore, we target these 
enzymes for our computational study. We report functional sites in these 
Nudix enzymes via GI method. Our predicted sites are also matching with 
the  residues  detected  by  PROFUNC  and  Patchfinder  servers.  However, 
these servers produced large number of amino acid residues.  
 
Furthermore, we also determine the substrate for the 2AZW and 2B06 via 
docking study. We find that the substrate ADP-Ribose shows more affinity 
for these Nudix enzymes as well as the residues EA62 (2B06) and RA62 
(2AZW)  interact  with  the  ADP-ribose  by  making  the  hydrogen  bonds. 
Note that these residues are also report by our GI method.  The residues in 
the predicted sites for 2B06 and 2AZW are also make hydrogen bonds with 
nearby  water  molecules,  leading  to  more  convincing  specificity  of  our 
functional  site  prediction.  In  addition,  we  determine  the  inhibitor 
compounds for these Nudix enzymes via docking.  Our study finds that the 
compounds AMPCPR and CID14258187 may act as potential inhibitors of 
2B06 and 2AZW. These compounds also bind within the same binding site 
pockets and residues of these Nudix enzymes, as shared by the substrate 
ADP-Ribose. In addition, the drug likeness properties analysis reveal that 
the  compound  CID14258187  (2R,  3R,  4S,  5R)-2-(6-aminopurin-9-yl)-5-
(dichlorophosphoryloxymethyl)  oxolane-3,  4-diol)  is  in  agreement  with 
Lipinski rule of 5 and can be act as potential drug against Streptococcus 
pneumoniae and Enterococcus faecalis pathogenic microorganisms.  
 
Conclusion: 
Our  work  concludes  that  the  functional  site  residues  predicted  by  GI 
method  are  putative  substrate  binding  site  residues  for  Nudix  enzymes 
2B06 and 2AZW. We also find that ADP-Ribose is their substrate, which 
infer  that  these  Nudix  enzymes  may  catalyze  the  catabolic  reaction  of 
ADP-Ribose in to AMP.  Our study also determines that the AMPCPR and 
CID14258187 may act as inhibitor compounds for these Nudix enzymes. 
As  these  Nudix  enzymes  are  from  pathogenic  microorganisms 
Streptococcus  pneumoniae  and  Enterococcus  faecalis,  therefore  these 
inhibitor  compounds  can  be  used  as  drug  compound  against  these 
microorganisms. Analysis of drug likeness properties also confirm that the 
compound  CID14258187  (2R,  3R,  4S,  5R)-2-(6-aminopurin-9-yl)-5-
(dichlorophosphoryloxymethyl)  oxolane-3,4-diol)  is  capable  to  act  as 
potential drug compound. These studies may help in designing new drugs 
against Streptococcus pneumoniae and Enterococcus faecalis. This is the 
most important contribution of this work given that the Nudix enzymes are 
potentially important drug targets due to their key role in these organisms 
survival.  
 
Acknowledgment: 
Funding:  Ashish  V  Tendulkar  and  Ashwani  Sharma  gratefully 
acknowledge support from innovative young biotechnologist award grant 
2008  from  Department  of  Biotechnology,  Govt.  of  India  and  CSIR 
fellowship, respectively. 
 
References : 
[1]  J L Cartwright et al. Journal of Virology 76: 1415 (2002) [PMID: 
11773415] 
[2]  T Ooga et al. Journal of Biological Chemistry. 284: 15549 (2009) 
[PMID: 19346251] 
[3]  S Sheikh et al. Journal of Biological Chemistry.273: 20924 (1998)  
[PMID: 9694840] 
[4]  J A Garza et al. Biochemistry. 48: 6224 (2009) [PMID: 19462967] 
[5]  A G McLennan et al. Cellular and Molecular Life Sciences. 63: 123 
(2006) [PMID: 16378245] Bioinformation  Volume 5  open access 
www.bioinformation.net  Issue 8  Hypothesis 
 
 
     
ISSN 0973-2063 (online) 0973-8894 (print)  346   
Bioinformation 5(8): 341-349 (2011)                       © 2011 Biomedical Informatics 
 
 
 
[6]  S  K  Bhatnagar  et  al.  Journal  of  Biological  Chemistry.263:  8953 
(1988) [PMID: 3288626] 
[7]  J Y Mo et al. PNAS.  89: 11021 (1992) [PMID: 1332067] 
[8]  C A Dunn et al. Journal of Biological Chemistry.274: 32318 (1999) 
[PMID: 10542272] 
[9]  J D Swarbrick et al. Journal of Molecular Biology.302: 1165 (2000) 
[PMID: 11183782] 
[10]  S Bailey et al. Structure. 10: 589 (2002)  [PMID: 11937063] 
[11]  M  J  Bessman  et  al.  Journal  of  Biological  Chemistry.271:  25059 
(1996) [PMID: 8810257] 
[12]  W   Xu et al. Journal of Biological Chemistry. 279: 24861 (2004) 
[PMID: 15060060] 
[13]  P H  Edelstein et al. Infection and Immunity. 73: 6567 (2005) [PMID: 
16177332] 
[14]  P P Wangikar et al. Journal of Molecular Biology.326: 955 (2003) 
[PMID: 12581652] 
[15]  A V Tendulkar et al. Journal of Molecular Biology.334: 157 (2003) 
[PMID: 14596807] 
[16]  G M  Morris et al. Journal of Computational Chemistry. 19: 1639 
(1998)  
[17]  D  Schneidman-Duhovny  et  al.  Nucleic  Acids  Research,  33:  W363 
(2005) [PMID: 15980490] 
 
Edited by P Kangueane 
Citation: Sharma et al. Bioinformation 5(8): 341-349 (2011) 
License statement: This is an open-access article, which permits unrestricted use, distribution, and reproduction in any medium, for non-commercial 
purposes, provided the original author and source are credited. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Bioinformation  Volume 5  open access 
www.bioinformation.net  Issue 8  Hypothesis 
 
 
     
ISSN 0973-2063 (online) 0973-8894 (print)  347   
Bioinformation 5(8): 341-349 (2011)                       © 2011 Biomedical Informatics 
 
 
 
Supplementary material: 
 
Table 1: Functional site predictions in  Structural Genomics (SG) unknown function proteins from Nudix family and their representative proteins. 
SG Nudix PDB  Cluster ID  Predicted Functional Site  Representative PDB and Functional Site 
2AZW  DDDK-1  RA62 EA63 EA66 EA67  1NQZ A:RA85 EA86 EA89 EA90 
2B06  DDDK-1  RA57 EA58 EA61 EA62  1SU2 A:RA64 EA65 EA68 EA69 
 
Table 2: Prediction of functional sites in Structural Genomics Nudix proteins 
 
Table 3: Docking analysis of substrates against Structural Genomics Nudix SG targets 
  Blind Docking 
Substrates  DE (-Kcal/mol) 
  2AZW  2B06 
ADP-RIBOSE  -10.86  -15.69 
AMP  -7.68  -10.51 
Apr  -10.79  -13.8 
ATP  -9.2  -11.2 
CTP  -8.92  -11.07 
dATP  -8.36  -11.56 
dGTP  -10.16  -11.99 
dTTP  -10  -12.23 
dUTP  -8.91  -10.97 
GTP  -10.46  -13.37 
TTP  -9.46  -11.1 
.8-OXY-dGTP  -10.04  -12.57 
  Refined docking 
Substrates  DE (-Kcal/mol) 
  2AZW  2B06 
ADP-RIBOSE  -10.96  -16.2 
.8-OXY-dGTP  -10  -10.1 
 
Table 4:  Comparisons of Drug likeness properties of selected inhibitor compounds 
Molecular Properties       
Parameter  CID 14258187  AMPCPR 
miLogP  0.274  -3.355 
TPSA  145.628  282.307 
natoms  23  36 
MW  384.116  557.346 
nON  10  18 
SG 
Targets 
Predicted 
Functional Site  PINTS  PROFUNC  PatchFinder 
2AZW  RA62 EA63 
EA66 EA67 
E51 G48  
E49 
Reverse Template Match: 
 YA22 GA48 YA101; YA22 GA47 EA63  
Ligand Binding: EA48 EA63 EA66 EA67 
 
GA47 GA48 EA54  RA62 EA63 
EA66 EA67   
2B06  RA57 EA58 
EA61 EA62 
None  Reverse Template Match: CA13 GA42 KA92; LA65 GA98 
WA110; CA13 PA41 EA62; PA41 EA62 SA103; CA13 GA42 
HA44 
Ligand Binding: HA44 GA43 EA58 EA62 EA105 
NA11 GA42 GA43 DA48 EA49 
RA57 EA58 EA61 EA62 GA64   Bioinformation  Volume 5  open access 
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nOHNH  4  9 
nviolations  0  3 
nrotb  4  9 
volume  274.916  424.322 
     
Drug Likeness       
Parameter  CID 14258187  AMPCPR 
GPCR ligand  0.08  -0.1 
Ion channel modulator  -1.14  -1.08 
Kinase inhibitor  0.36  -0.25 
Nuclear receptor ligand  -2.38  -1.79 
 
Table 5: Matching cluster and template proteins for SG Nudix enzyme 
Cluster member  No.  Pattern  EC number  Function   
DDDK-1  4      hydrolase activity|1.00   
1KTG  EEER  EA52 EA55 EA56 RA51    bis(5'-nucleosyl)-tetraphosphatase activity ,hydrolase activity  Nudix 
1NQZ  EEER  EA86 EA89 EA90 RA85    hydrolase activity  Nudix 
1VHZ  EEER  EA95 EA98 EA99 RA94    hydrolase activity  Nudix 
1SU2  EEER  EA65 EA68 EA69 RA64    hydrolase activity  Nudix 
           
DDDK-2  3      hydrolase activity|1.00   
1VHZ  EEER  EA86 EA95 EA98 RA94    hydrolase activity  Nudix 
1VK6  EEER  EA165 EA174 EA177 RA173  3.6.1.22  hydrolase activity  Nudix 
1KTG  EEER  EA43 EA52 EA55 RA51    bis(5'-nucleosyl)-tetraphosphatase activity,hydrolase activity  Nudix 
           
DDDK-3  3      hydrolase activity|1.00   
1VK6  EEER  EA174 EA177 EA178 RA173  3.6.1.22  hydrolase activity  Nudix 
1KTG  EEER  EA52 EA55 EA56 RA51    bis(5'-nucleosyl)-tetraphosphatase activity,hydrolase activity  Nudix 
1VHZ  EEER  EA95 EA98 EA99 RA94    hydrolase activity  Nudix 
           
 
Table 6: Docking analysis of the Inhibitors with Nudix enzyme 
Pubchem compound  2B06      Pubchem compound  2AZW 
CID ID  Docking score     CID ID  Docking score 
AMPCPR_pdb  5292    AMPCPR_pdb  4902 
ADP-Ribose  5174    ADP-Ribose  4512 
14258187.pdb  4888    14258187.pdb  4268 
18657710.pdb  4876    18657710.pdb  4038 
18950508.pdb  4876    18950508.pdb  4038 
44442324.pdb  4818    46192071.pdb  4036 
46192071.pdb  4790    44442324.pdb  4012 
CID44299525.pdb  4512    CID44299525.pdb  3806 
CID46875160.pdb  4512    CID46875160.pdb  3806 
4131.pdb  4454    44442322.pdb  3786 
445093.pdb  4454    16678017.pdb  3766 
44574756.pdb  4408    44574718.pdb  3698 
16678017.pdb  4364    21724899.pdb  3602 
44442322.pdb  4312    4131.pdb  3576 
21724899.pdb  4260    445093.pdb  3576 
44574718.pdb  4258    44574756.pdb  3576 
6338568.pdb  4202    22497880.pdb  3472 Bioinformation  Volume 5  open access 
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14185387.pdb  4202    22827299.pdb  3472 
22497880.pdb  4152    21462459.pdb  3420 
22827299.pdb  4152    22827300.pdb  3420 
2024.pdb  4048    2024.pdb  3376 
101812.pdb  4048    101812.pdb  3376 
2735269.pdb  4048    2735269.pdb  3376 
7173835.pdb  4048    7173835.pdb  3376 
25632541.pdb  4048    25632541.pdb  3376 
25632546.pdb  4048    25632546.pdb  3376 
25632550.pdb  4048    25632550.pdb  3376 
25796534.pdb  4048    25796534.pdb  3376 
CID26967481.pdb  4048    CID26967481.pdb  3376 
CID46780086.pdb  4048    CID46780086.pdb  3376 
CID46780087.pdb  4048    CID46780087.pdb  3376 
6992262.pdb  4026    6992262.pdb  3346 
7173834.pdb  4026    7173834.pdb  3346 
25632540.pdb  4026    25632540.pdb  3346 
25632545.pdb  4026    25632545.pdb  3346 
25632549.pdb  4026    25632549.pdb  3346 
25796533.pdb  4026    25796533.pdb  3346 
CID26967480).pdb  4026    CID26967480).pdb  3346 
21462459.pdb  4010    6338568.pdb  3340 
22827300.pdb  4010    14185387.pdb  3340 
16131893.pdb  3916    16131893.pdb  3330 
16212025.pdb  3888    16212025.pdb  3164 
23902375.pdb  3888    23902375.pdb  3164 
25322946.pdb  3888    25322945.pdb  3164 
25322948.pdb  3888    25322946.pdb  3164 
40467852.pdb  3888    25322947.pdb  3164 
44629928.pdb  3888    25322948.pdb  3164 
25322945.pdb  3810    26940520.pdb  3164 
25322947.pdb  3810    40467851.pdb  3164 
26940520.pdb  3810    40467852.pdb  3164 
40467851.pdb  3810    40467853.pdb  3164 
40467853.pdb  3810     44629928.pdb  3164 
 